Clin Cancer Res. 2008 Feb 15;14(4):951-6.

Molecular pathways mediating liver metastasis in patients with uveal melanoma.

Bakalian S, Marshall JC, Logan P, Faingold D, Maloney S, Di Cesare S, Martins C, Fernandes BF, Burnier MN Jr.

Source

Henry C. Witelson Ocular Pathology Laboratory, McGill University, Montreal, Quebec, Canada. sbakalian@hotmail.com

Abstract

Uveal melanoma arises from melanocytes located in the uveal tract of the eye and is the most common primary intraocular tumor in adults. Metastatic liver disease is the overwhelming cause of death in uveal melanoma patients, with almost 50% of patients developing liver metastases up to 15 years after diagnosis. Most of these patients do not present with any evidence of overt metastasis at the time of initial diagnosis although it is assumed that they have undetectable micrometastases. Currently, there are no therapeutic modalities to prevent or efficiently treat the metastatic disease in uveal melanoma patients. Recent discoveries have shed light on the molecular pathways that may contribute to the progression of liver metastasis. The aim of this review is to describe new insights into the genetic and molecular pathways that may play a role in the development of liver metastases in uveal melanoma patients.

PMID:: 18281525; [PubMed - indexed for MEDLINE]

Free full text

Publication Types, MeSH Terms

Publication Types

Review

MeSH Terms

LinkOut - more resources

Full Text Sources

HighWire Press

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Medical

Supplemental Content

Save items

Related citations in PubMed

Modeling the behavior of uveal melanoma in the liver. [Invest Ophthalmol Vis Sci. 2007]
Modeling the behavior of uveal melanoma in the liver.
Folberg R, Leach L, Valyi-Nagy K, Lin AY, Apushkin MA, Ai Z, Barak V, Majumdar D, Pe'er J, Maniotis AJ. Invest Ophthalmol Vis Sci. 2007 Jul; 48(7):2967-74.
Osteopontin expression and serum levels in metastatic uveal melanoma: a pilot study. [Invest Ophthalmol Vis Sci. 2006]
Osteopontin expression and serum levels in metastatic uveal melanoma: a pilot study.
Kadkol SS, Lin AY, Barak V, Kalickman I, Leach L, Valyi-Nagy K, Majumdar D, Setty S, Maniotis AJ, Folberg R, et al. Invest Ophthalmol Vis Sci. 2006 Mar; 47(3):802-6.
Post-menopausal bleeding: a rare presentation of metastatic uveal melanoma. [Pathol Oncol Res. 2006]
Post-menopausal bleeding: a rare presentation of metastatic uveal melanoma.
Coutts MA, Borthwick NJ, Hungerford JL, Cree IA. Pathol Oncol Res. 2006; 12(3):184-7. Epub 2006 Sep 23.
Review Locoregional management of hepatic metastasis from primary uveal melanoma. [Semin Oncol. 2010]
Review Locoregional management of hepatic metastasis from primary uveal melanoma.
Sato T. Semin Oncol. 2010 Apr; 37(2):127-38.
Review Update on posterior uveal melanoma: treatment of the eye and emerging strategies in the prognosis and treatment of metastatic disease. [Curr Opin Ophthalmol. 2009]
Review Update on posterior uveal melanoma: treatment of the eye and emerging strategies in the prognosis and treatment of metastatic disease.
Shildkrot Y, Wilson MW. Curr Opin Ophthalmol. 2009 Nov; 20(6):504-10.

See reviews... See all...

Cited by 6 PubMed Central articles

The protein kinase C inhibitor enzastaurin exhibits antitumor activity against uveal melanoma. [PLoS One. 2012]
The protein kinase C inhibitor enzastaurin exhibits antitumor activity against uveal melanoma.
Wu X, Zhu M, Fletcher JA, Giobbie-Hurder A, Hodi FS. PLoS One. 2012; 7(1):e29622. Epub 2012 Jan 12.
Uveal melanoma. [J Skin Cancer. 2011]
Uveal melanoma.
Papastefanou VP, Cohen VM. J Skin Cancer. 2011; 2011:573974. Epub 2011 Jun 30.
New horizons in melanoma treatment: targeting molecular pathways. [Ochsner J. 2010]
New horizons in melanoma treatment: targeting molecular pathways.
Soon CW, Algazi AP, Cha EN, Daud AI. Ochsner J. 2010 Summer; 10(2):93-8.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Molecular pathways mediating liver metastasis in patients with uveal melanoma.
Molecular pathways mediating liver metastasis in patients with uveal melanoma.
Clin Cancer Res. 2008 Feb 15 ;14(4):951-6.

PubMed
A new mechanism of drug resistance in breast cancer cells: fatty acid synthase o...
A new mechanism of drug resistance in breast cancer cells: fatty acid synthase overexpression-mediated palmitate overproduction.
Mol Cancer Ther. 2008 Feb ;7(2):263-70.

PubMed
Promoter hypermethylation of the PALB2 susceptibility gene in inherited and spor...
Promoter hypermethylation of the PALB2 susceptibility gene in inherited and sporadic breast and ovarian cancer.
Cancer Res. 2008 Feb 15 ;68(4):998-1002.

PubMed
Prohibitins control cell proliferation and apoptosis by regulating OPA1-dependen...
Prohibitins control cell proliferation and apoptosis by regulating OPA1-dependent cristae morphogenesis in mitochondria.
Genes Dev. 2008 Feb 15 ;22(4):476-88.

PubMed
Fluoxetine versus placebo in preventing relapse of major depression in children ...
Fluoxetine versus placebo in preventing relapse of major depression in children and adolescents.
Am J Psychiatry. 2008 Apr ;165(4):459-67. Epub 2008 Feb 15 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: